MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study.

@article{Koehrmann2006MRIVC,
  title={MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study.},
  author={Martin Koehrmann and Eric Juettler and Jochen B. Fiebach and Hagen Bernhard Huttner and Stefan Siebert and Christian Schwark and P A Ringleb and Peter Dieter Schellinger and Werner Hacke},
  journal={The Lancet. Neurology},
  year={2006},
  volume={5 8},
  pages={661-7}
}
BACKGROUND Thrombolytic treatment with recombinant tissue plasminogen activator (rtPA) is approved for use within 3 h after stroke onset. Thus only a small percentage of patients can benefit. Meta-analyses and more recent studies suggest a benefit for a subset of patients beyond 3 h. We assessed the safety and efficacy of an MRI-based selection protocol for stroke treatment within and beyond 3 h compared with standard CT-based treatment. METHODS We assessed clinical outcome and incidence of… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 68 extracted citations

Similar Papers

Loading similar papers…